6.97
price down icon11.99%   -0.95
after-market Handel nachbörslich: 7.15 0.18 +2.58%
loading

Gyre Therapeutics Inc Aktie (GYRE) Neueste Nachrichten

pulisher
12:54 PM

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 4.7%Time to Sell? - MarketBeat

12:54 PM
pulisher
03:07 AM

Gyre Therapeutics, Inc. Announces Completion of the Pre-NDA Meeting on the Regulatory Strategy for F351 - marketscreener.com

03:07 AM
pulisher
Jan 05, 2026

GNI Group’s F351 Secures Path Toward Conditional Approval and Priority Review in China - TipRanks

Jan 05, 2026
pulisher
Jan 05, 2026

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap UpShould You Buy? - MarketBeat

Jan 05, 2026
pulisher
Jan 05, 2026

Gyre Therapeutics stock soars after positive pre-NDA meeting in China - Investing.com

Jan 05, 2026
pulisher
Jan 05, 2026

Altimmune, GH Research, Gyre Therapeutics And Other Big Stocks Moving Higher On Monday - Benzinga

Jan 05, 2026
pulisher
Jan 05, 2026

Gyre Pharmaceuticals advances liver fibrosis drug toward China approval By Investing.com - Investing.com Canada

Jan 05, 2026
pulisher
Jan 05, 2026

Gyre Therapeutics Announces Pre-NDA Meeting Success for Hydronidone - TradingView — Track All Markets

Jan 05, 2026
pulisher
Jan 05, 2026

Gyre Therapeutics Announces Alignment with China’s CDE on Conditional Approval Pathway and Priority Review Eligibility for Hydronidone Following Pre-NDA Meeting - The Manila Times

Jan 05, 2026
pulisher
Jan 05, 2026

Experimental liver fibrosis drug in China moves closer to patient use - Stock Titan

Jan 05, 2026
pulisher
Jan 04, 2026

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Given Average Rating of "Hold" by Analysts - MarketBeat

Jan 04, 2026
pulisher
Dec 29, 2025

Gyre Therapeutics president sells $45,380 in stock - MSN

Dec 29, 2025
pulisher
Dec 26, 2025

Undiscovered Gems in the US Market to Explore This December 2025 - Yahoo Finance

Dec 26, 2025
pulisher
Dec 21, 2025

Published on: 2025-12-21 18:19:37 - Улправда

Dec 21, 2025
pulisher
Dec 21, 2025

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 3.6% – Time to Sell? - Defense World

Dec 21, 2025
pulisher
Dec 20, 2025

Will Gyre Therapeutics Inc. stock keep outperforming rivalsJuly 2025 Breakouts & Low Drawdown Investment Strategies - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Gyre Therapeutics Earnings Notes - Trefis

Dec 19, 2025
pulisher
Dec 19, 2025

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 3.6%Time to Sell? - MarketBeat

Dec 19, 2025
pulisher
Dec 19, 2025

Why Gyre Therapeutics Inc. stock remains on buy lists2025 Trading Recap & Long-Term Capital Growth Strategies - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Levels Update: Is Gyre Therapeutics Inc. stock vulnerable to regulatory risks2025 Major Catalysts & Weekly Momentum Picks - Улправда

Dec 19, 2025
pulisher
Dec 18, 2025

Will Gyre Therapeutics Inc. stock deliver consistent dividends2025 Market WrapUp & Reliable Price Action Trade Plans - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Does Gyre Therapeutics Inc. stock trade at a discount to peers2025 Geopolitical Influence & AI Driven Price Forecasts - Улправда

Dec 18, 2025
pulisher
Dec 15, 2025

Gyre therapeutics president Ma Songjiang sells $45,434 in stock - MSN

Dec 15, 2025
pulisher
Dec 15, 2025

US High Growth Tech Stocks to Watch - Yahoo Finance

Dec 15, 2025
pulisher
Dec 13, 2025

Gyre Therapeutics president Ma Songjiang sells $42,480 in stock - MSN

Dec 13, 2025
pulisher
Dec 12, 2025

Gyre Therapeutics (NASDAQ:GYRE) Shares Down 5.9%Should You Sell? - MarketBeat

Dec 12, 2025
pulisher
Dec 10, 2025

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat

Dec 10, 2025
pulisher
Dec 10, 2025

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Receives Average Recommendation of “Hold” from Brokerages - Defense World

Dec 10, 2025
pulisher
Dec 09, 2025

GNI Group’s Subsidiary Completes Enrollment for Key Clinical Trial - MSN

Dec 09, 2025
pulisher
Dec 09, 2025

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 2.3%Time to Buy? - MarketBeat

Dec 09, 2025
pulisher
Dec 07, 2025

Gyre Therapeutics (GYRE) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 07, 2025
pulisher
Dec 04, 2025

Is Gyre Therapeutics Stock Built to Withstand a Pullback? - Trefis

Dec 04, 2025
pulisher
Nov 30, 2025

Regarding video postings related to our company group information on some social networking services (SNS). - 富途牛牛

Nov 30, 2025
pulisher
Nov 26, 2025

Published on: 2025-11-27 08:38:09 - moha.gov.vn

Nov 26, 2025
pulisher
Nov 23, 2025

Is Gyre Therapeutics Inc a good long term investmentMarket Depth Overview & Free Unmatched Market Performance - earlytimes.in

Nov 23, 2025
pulisher
Nov 21, 2025

Is Gyre Therapeutics Inc. stock a dividend growth opportunity2025 Short Interest & Real-Time Volume Triggers - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is Gyre Therapeutics Inc. stock dividend yield sustainableJuly 2025 Closing Moves & Safe Entry Point Identification - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

What drives Gyre Therapeutics Inc stock priceMarket Capitalization Trends & Free Triple Digit Wealth Increase - earlytimes.in

Nov 21, 2025
pulisher
Nov 21, 2025

Will Gyre Therapeutics Inc. stock return to pre crisis levelsLong Setup & Low Risk High Win Rate Picks - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Should I hold or sell Gyre Therapeutics Inc. stock in 2025July 2025 Final Week & Verified Technical Signals - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Why Gyre Therapeutics Inc. stock remains on watchlistsMarket Activity Report & Weekly Chart Analysis and Guides - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

What recovery options are there for Gyre Therapeutics Inc.2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Gyre Therapeutics Inc. stock sustain institutional interest2025 Biggest Moves & Smart Money Movement Tracker - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Gyre Therapeutics Inc. stock performs in interest rate cyclesMarket Activity Recap & Daily Volume Surge Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Gyre Therapeutics Inc. stock entering bullish territoryTrade Entry Summary & Long-Term Safe Investment Ideas - newser.com

Nov 19, 2025
$40.65
price up icon 2.52%
$33.10
price up icon 4.09%
$106.66
price up icon 4.78%
$98.09
price up icon 1.28%
biotechnology ONC
$320.35
price up icon 0.02%
$175.07
price down icon 0.07%
Kapitalisierung:     |  Volumen (24h):